POPatrick Godwin Okwute

Patrick Godwin Okwute

*This is an algorithmically generated author record based on publicly available information.

Patrick Godwin Okwute has a total of 6 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Gut Microbiota Modulation in Parkinson’s Disease: Exploring Phytotherapy, Pharmacotherapy, and Precision Interventions

    by Samuel Oluwadare Olalekan, Patrick Godwin Okwute, Ifabunmi Oduyemi Osonuga, Adekunle Muiz Mofolorunso, Bukunola Oluyemisi Adegbesan, Esther Nkechi Ezima, Gideon Olamilekan Oluwatunase

    Parkinson’s disease (PD) is a progressive neurodegenerative disorder with growing evidence implicating gut microbiota dysbiosis in its pathogenesis. Recent research highlights the gut-brain axis as a crucial therapeutic target, with interventions such as phytotherapy, pharmacotherapy, and precision medicine emerging as promising approaches. Phytotherapy, including plant-derived compounds like curcumin and dioscin, has demonstrated neuroprotective effects by modulating gut microbiota, reducing neuroinflammation, and enhancing short-chain fatty acid production. Pharmacotherapy, particularly levodopa, remains the primary treatment for PD motor symptoms, but its interactions with gut microbiota can affect drug metabolism, necessitating microbiota-targeted strategies such as enzyme inhibitors and antibiotic co-administration. Precision interventions, including probiotics, prebiotics, synbiotics, dietary modifications, and fecal microbiota transplantation, aim to restore microbial balance and improve gut-brain axis function. This chapter explores the mechanisms, clinical outcomes, and limitations of these interventions, emphasizing the need for integrative and personalized therapeutic approaches. By targeting gut microbiota, these strategies hold potential for optimizing PD management, enhancing treatment efficacy, and improving patient quality of life.